Literature DB >> 10843423

Evidence of eosinophil, neutrophil, and mast-cell mediators in the effusion of OME patients with and without atopy.

D S Hurst1, P Venge.   

Abstract

BACKGROUND: This study was designed to measure the involvement of eosinophils, neutrophils, and mast cells in the middle ear of patients with OME and to see whether that inflammatory response differed depending on whether or not the patient was atopic.
METHODS: Levels of ECP, MPO, and tryptase were measured in effusion from 97 patients whose atopic status was determined by in vitro testing with 12 inhalants and five foods.
RESULTS: Seventy-nine of 97 OME patients (81%) were atopic, among whom 86% (68/79) had elevated levels of effusion ECP, and 64% (23/36) had elevated tryptase. Mean ECP was 166 microg/l vs 3.38 microg/l, mean MPO was 6231 microg/l vs 116 microg/l, and mean tryptase was 4.8 microg/l vs 1.34 microg/l in atopic vs nonatopic ears. Total serum IgE did not differ between atopics and nonatopics (P=0.28).
CONCLUSIONS: The inflammatory response by eosinophils, neutrophils, and mast cells in the middle ear was distinctly different between atopic and nonatopic patients (P < 0.001). This study provides evidence that eosinophils and mast cells, both essential to a Th-2 driven immune response, are present in the majority of ears with chronic OME, and supports the hypothesis that middle-ear mucosa, like that of the rest of the upper respiratory tract, is capable of an allergic response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843423     DOI: 10.1034/j.1398-9995.2000.00289.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  17 in total

1.  Effects of Allergina on the treatment of otitis media with effusions.

Authors:  Hyun-Ja Jeong; Seung-Heon Hong; Sung-Chul Kim; Eun-Jeong Park; Chul-Ho Jang; Kyung-Suk Kim; Hyung-Min Kim
Journal:  Inflammation       Date:  2002-04       Impact factor: 4.092

2.  The role of atopy in otitis media with effusion among primary school children: audiological investigation.

Authors:  F Martines; G Martinciglio; E Martines; D Bentivegna
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06-09       Impact factor: 2.503

Review 3.  Is there an association between otitis media and nasal polyposis?

Authors:  Cécile Parietti-Winkler; Roger Jankowski
Journal:  Curr Allergy Asthma Rep       Date:  2011-12       Impact factor: 4.806

Review 4.  Glucocorticosteroids in allergic inflammation: clinical benefits in otitis media with effusion.

Authors:  Ingeborg Dhooge; Katia Verbruggen; Liesbet Vandenbulcke
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

Review 5.  Does the type of rhinitis influence development of otitis media with effusion in children?

Authors:  Nicola Quaranta; Lucia Iannuzzi; Matteo Gelardi
Journal:  Curr Allergy Asthma Rep       Date:  2014-11       Impact factor: 4.806

Review 6.  Role of innate immunity in the pathogenesis of otitis media.

Authors:  Rahul Mittal; Joyson Kodiyan; Robert Gerring; Kalai Mathee; Jian-Dong Li; M'hamed Grati; Xue Zhong Liu
Journal:  Int J Infect Dis       Date:  2014-11-05       Impact factor: 3.623

Review 7.  Audiological investigation of otitis media in children with atopy.

Authors:  Francesco Martines; Daniela Bentivegna
Journal:  Curr Allergy Asthma Rep       Date:  2011-12       Impact factor: 4.806

8.  The point prevalence of otitis media with effusion among primary school children in Western Sicily.

Authors:  Francesco Martines; Daniela Bentivegna; Fabiola Di Piazza; Gioacchino Martinciglio; Vincenzo Sciacca; Enrico Martines
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-27       Impact factor: 2.503

Review 9.  Interaction Between Allergy and Middle Ear Infection.

Authors:  Jeong-Hoon Oh; Woo Jin Kim
Journal:  Curr Allergy Asthma Rep       Date:  2016-09       Impact factor: 4.806

10.  [Recurrent otitis media with effusion in childhood : when should an otolaryngologist consider an allergic etiology?].

Authors:  M Damm; K P Jayme; L Klimek
Journal:  HNO       Date:  2013-10       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.